Browse Category

Stocks News 29 December 2025 - 30 December 2025

NuScale Power (SMR) stock slips in premarket as SMR doubts weigh on nuclear names

NuScale Power (SMR) stock slips in premarket as SMR doubts weigh on nuclear names

NEW YORK, December 30, 2025, 04:49 ET — Premarket NuScale Power shares fell 2.4% to $14.48 in premarket trading on Tuesday, after ending the prior session at about $14.84. The move matters because “advanced nuclear” stocks have become a high-beta pocket of the market into year-end, swinging sharply on sentiment rather than earnings power. For investors, the debate has shifted from “who wins the SMR race” to “who can fund it without punishing shareholders.” Small modular reactors, or SMRs, are smaller nuclear units designed to be built largely in factories and deployed in modules. Backers pitch faster construction and easier
Micron stock today: MU jumps in premarket as memory-supply headlines keep traders on edge

Micron stock today: MU jumps in premarket as memory-supply headlines keep traders on edge

NEW YORK, December 30, 2025, 04:59 ET — Premarket Micron Technology shares were up 3.4% in premarket trading on Tuesday, indicating a move to about $294.37. The early rise comes as memory-chip stocks remain keyed to supply headlines. A Reuters report said the U.S. granted Samsung Electronics and SK Hynix annual licences for 2026 to bring chipmaking equipment into their China facilities, a development that could influence output at two major Micron rivals. Reuters Macro catalysts also loom large into year-end, when liquidity can be thin and price swings can look bigger than they are. The dollar held steady ahead
Outlook Therapeutics stock jumps ahead of FDA’s Dec. 31 Lytenava decision

Outlook Therapeutics stock jumps ahead of FDA’s Dec. 31 Lytenava decision

NEW YORK, December 30, 2025, 01:25 ET — Market closed Outlook Therapeutics, Inc. shares closed Monday up 8.8% at $1.98 after trading between $1.78 and $1.98. The stock was last up about 2% at $2.02 in late after-hours trading, with about 5.7 million shares changing hands. StockAnalysis Traders are zeroed in on a Dec. 31 deadline at the U.S. Food and Drug Administration for Lytenava (ONS-5010), the company’s wet age-related macular degeneration candidate. A Nov. 13 filing showed the FDA set a Prescription Drug User Fee Act, or PDUFA, goal date of Dec. 31 — the agency’s target date for
Energy Transfer stock today: ET edges up as oil jumps, with pipeline risks and earnings in focus

Energy Transfer stock today: ET edges up as oil jumps, with pipeline risks and earnings in focus

NEW YORK, December 30, 2025, 01:09 ET — Market closed Energy Transfer LP’s units closed up 0.12% at $16.27 on Monday, after trading between $16.24 and $16.34. Volume was about 11.8 million units. The modest move matters because Energy Transfer sits in the midstream pipeline group, where investors focus on cash payouts and steady fee revenue rather than big swings in commodity prices. Midstream operators are sometimes described as “toll roads” for oil and gas: they earn fees to move and store fuel. That can cushion earnings when oil and gas prices whip around, but the units still trade with
BNAI stock doubles as Brand Engagement Network lands AI pharma deal, eyes recurring fees

BNAI stock doubles as Brand Engagement Network lands AI pharma deal, eyes recurring fees

NEW YORK, December 29, 2025, 23:20 ET — Market closed Brand Engagement Network, Inc shares more than doubled on Monday after the company disclosed a project agreement to develop a custom AI engagement tool tied to an established prescription drug for a top-10 global pharmaceutical client. The company said it expects $250,000 in fourth-quarter development revenue and anticipates monthly license fees starting in the first quarter of 2026; the stock closed up 108.8% at $2.51. SEC+1 The agreement offers a near-term revenue catalyst for a thinly traded AI microcap trying to prove it can turn pilot work into repeatable contracts
Honeywell stock edges down after $58.8 million Army contract update as Fed minutes loom

Honeywell stock edges down after $58.8 million Army contract update as Fed minutes loom

NEW YORK, December 29, 2025, 23:07 ET — Market closed Honeywell International Inc. shares ended down 0.14% at $197.09 on Monday and eased to $196.89 in after-hours trading, as investors weighed a small U.S. Army contract update against a softer broader market into year-end. The stock traded between $196.24 and $197.60 during the session and remains within a 52-week range of $168.99 to $227.71. Google The move matters now because markets are running on light liquidity with just a handful of sessions left in 2025, leaving investors quick to react to incremental headlines. Honeywell’s defense- and aerospace-linked work can offer
Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

NEW YORK, December 29, 2025, 22:17 ET — Market closed Gilead Sciences (GILD.O) shares were last up 0.15% at $124.91 on Monday, as investors weighed an analyst note that argued new Medicaid drug-pricing rules would have a limited financial impact on the company’s HIV franchise. Investing.com The call matters now because drugmakers and investors are still parsing a Trump administration pricing push that targets Medicaid and aims to bring U.S. medicine prices closer to those in other wealthy countries. Reuters For Gilead, the focus has been on whether “most-favored-nation” pricing — a policy that effectively ties prices to lower international
Boeing stock edges up after-hours as Pentagon posts $8.6 billion F-15 deal — what investors watch next

Boeing stock edges up after-hours as Pentagon posts $8.6 billion F-15 deal — what investors watch next

NEW YORK, December 29, 2025, 19:30 ET — After-hours Boeing stock (BA) was up 0.4% at $217.25 in after-hours trading on Monday after the Pentagon posted an $8.6 billion award for Israel’s F-15 program. Boeing traded between $215.18 and $218.35 during the session. Reuters The headline matters because Boeing’s defense business can add long-dated revenue visibility while investors scrutinize whether the broader turnaround is sticking. New contract wins help support backlog, but they do not settle the near-term debate around execution and cash generation that has dominated trading in the stock. It also lands in thin, year-end markets, when single
Strategy (MSTR) stock slips after-hours after SEC filing details fresh $108.8 million bitcoin buy

Strategy (MSTR) stock slips after-hours after SEC filing details fresh $108.8 million bitcoin buy

NEW YORK, December 29, 2025, 16:47 ET — After-hours Strategy Inc (MSTR) shares were last down 2.2% at $155.39 in after-hours trading on Monday after the company disclosed another bitcoin purchase funded by selling new shares. SEC The move matters because Strategy has positioned itself as a “Bitcoin Treasury Company,” tying its equity more tightly to bitcoin’s swings than most U.S. software stocks. Strategy Investors have also become more sensitive to dilution — when issuing new stock reduces existing shareholders’ ownership percentage — as Strategy continues to tap capital markets to accumulate the cryptocurrency. Bitcoin was down about 0.3% at
Western Digital (WDC) stock slips today as year-end tech pullback tests AI-storage rally

Western Digital (WDC) stock slips today as year-end tech pullback tests AI-storage rally

NEW YORK, December 29, 2025, 15:23 ET — Regular session Shares of Western Digital Corp fell about 0.8% to $180.15 by mid-afternoon in New York on Monday, trimming gains after an intraday rebound from the session’s low. The dip matters now because Western Digital has been a standout winner in 2025, leaving little room for disappointment as investors head into the new year. Barron’s said the stock is up about 303% in 2025, putting it at the top of the S&P 500’s leaderboard. Barron’s With markets entering the last stretch of the year, moves can look larger than the day’s
Merck (MRK) stock holds steady as Wall Street cools into year-end trade

Merck (MRK) stock holds steady as Wall Street cools into year-end trade

NEW YORK, December 29, 2025, 3:12 PM ET — Regular session Merck & Co shares were little changed on Monday afternoon, up 0.01% at $106.79. The muted move mattered because investors have been shifting toward steadier corners of the market as 2025 winds down, a period that can amplify small price swings on lighter volumes. Health-care stocks largely held their ground, with the Health Care Select Sector SPDR ETF down 0.05%, as traders stayed selective in year-end positioning. Wall Street’s main indexes slipped as heavyweight technology names retreated from last week’s gains. “This is (not) the beginning of the end
Circle (CRCL) stock slips today as prediction-market growth call collides with year-end trading

Circle (CRCL) stock slips today as prediction-market growth call collides with year-end trading

NEW YORK, December 29, 2025, 14:45 ET — Regular session Circle Internet Group, Inc. shares slipped on Monday, down about 0.8% at $80.62 in afternoon trading. The stock has moved between $78.96 and $82.96 so far in the session. The move matters now because Circle has become one of the market’s most direct listed bets on stablecoins — digital tokens designed to hold a steady value, typically by tracking the U.S. dollar. That ties investor expectations to both adoption trends in crypto payments and the path of U.S. interest rates. It also comes as investors parse where the next wave
1 46 47 48 49 50 103

Stock Market Today

Corning stock price hits record close — what’s driving GLW and the next big test

Corning stock price hits record close — what’s driving GLW and the next big test

7 February 2026
Corning shares jumped 8.3% to a record $122.16 Friday, gaining 11% over two sessions amid strong demand for AI infrastructure stocks. The move follows a $6 billion optical fiber deal with Meta and upgraded company forecasts. Shares traded as high as $122.56 and rose 0.6% after hours. COO Avery Nelson sold 1,894 shares for tax withholding, retaining 66,050.
PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
PepsiCo priced €2.5 billion in euro notes across four maturities, with settlement set for Feb. 11, according to an SEC filing. The company plans to use proceeds for general corporate purposes, including repaying commercial paper. Shares closed at $170.49 Friday, up 1.8%. PepsiCo is also cutting U.S. snack prices by up to 15% after consumer pushback.
Go toTop